Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.

BioMed research international - 1 Jan 2019

Chen Chao, Zhou Qiming, Wu Riping, Li Bo, Chen Qiang, Zhang Xiuqing, Shi Chunmei

Abstract excerpt

Immunotherapy directed against cancer-specific neoantigens derived from non-silent mutants is a promising individualized strategy for cancer treatment. Neoantigens shared across patients could be used as a public resource for developing T cell-based therapy. To identify potential public neoantigens for therapy in gastric cancer (GC), 74 GC patients were enrolled in this study. Combined with the TCGA cohort and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cell- and Tissue-Based Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Databases, Genetic

Share to Immunotherapy

Share to Stomach Neoplasms

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 31781598
DOI: 10.1155/2019/2183510
PMCID: PMC6874998

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.PMID 31781598Read ↗

Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric CancerSemantic proximity Read ↗

A Comprehensive Survey of Mutations in Oesophageal Carcinoma Reveals Recurrent Neoantigens as Potential Immunotherapy TargetsSemantic proximity Read ↗

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.Semantic proximity Read ↗

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy TargetsSemantic proximity Read ↗

Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersSemantic proximity Read ↗

The Role of Neoantigens in Cancer ImmunotherapySemantic proximity Read ↗

[A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library].Semantic proximity Read ↗

Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.Semantic proximity Read ↗

Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.Semantic proximity Read ↗

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic TargetsSemantic proximity Read ↗

A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic TargetsSemantic proximity Read ↗

Beyond tumor mutation burden: tumor neoantigen burden as a superior prognostic biomarker in resected gastric cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.